Expansion leverages proprietary chromatography expertise to overcome purification bottlenecks and secure domestic API manufacturing
SK pharmteco, a global contract development and manufacturing organization serving the pharmaceutical industry, today announced that David Lowndes will be appointed as Chief Operating Officer.
SK pharmteco, a global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry, today announced that Joerg Ahlgrimm will be appointed as the Chief Executive Officer.
SK pharmteco, world-leaders in Continuous Flow Processing are hosting a free 1-Day Symposium for customers and key contacts on Thursday, October 13th at the Le Meridien Hotel, Cambridge, Boston, MA.
SK pharmteco (SKPT) a global CDMO, part of SK Inc., is pleased to announce Dollar 35m investment for the initial phase of an expansion plan for SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant.
Highlights from our discussion with Dr Bill DuBay, Vice President of Global Research and Development at SK pharmteco.
